Yes thanks for this!
The Kraus talk looked like a key one, youtube link below. In it she actualy says around 12 minutes...."Biomarkers DO exist....that are reasonably likely to predict importnant benefits to patients", and pointing to the AD aducanumab approval as a precedent that should pave the way for an Accelerated Approval in OA. Just wow.
- Forums
- ASX - By Stock
- PAR
- research reports and media
research reports and media, page-3191
-
- There are more pages in this discussion • 1,214 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
|
|||||
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M |
Open | High | Low | Value | Volume |
23.5¢ | 24.0¢ | 22.5¢ | $186.1K | 801.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 33599 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 65498 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 20000 | 0.230 |
4 | 130009 | 0.225 |
12 | 183076 | 0.220 |
6 | 98958 | 0.215 |
9 | 260864 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 65498 | 1 |
0.245 | 48923 | 2 |
0.250 | 3443 | 1 |
0.260 | 58362 | 1 |
0.270 | 5000 | 1 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
PAR (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online